Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Dexcom (DXCM) Leases (2019 - 2025)

Dexcom (DXCM) has disclosed Leases for 11 consecutive years, with $77.4 million as the latest value for Q4 2025.

  • Quarterly Leases rose 23.25% to $77.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $77.4 million through Dec 2025, up 23.25% year-over-year, with the annual reading at $77.4 million for FY2025, 23.25% up from the prior year.
  • Leases for Q4 2025 was $77.4 million at Dexcom, up from $54.0 million in the prior quarter.
  • The five-year high for Leases was $98.8 million in Q1 2021, with the low at $54.0 million in Q3 2025.
  • Average Leases over 5 years is $75.1 million, with a median of $74.8 million recorded in 2023.
  • The sharpest move saw Leases surged 33.88% in 2021, then decreased 20.79% in 2025.
  • Over 5 years, Leases stood at $88.1 million in 2021, then dropped by 9.19% to $80.0 million in 2022, then dropped by 10.75% to $71.4 million in 2023, then fell by 12.04% to $62.8 million in 2024, then increased by 23.25% to $77.4 million in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $77.4 million, $54.0 million, and $56.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.